Insider: Gibson Christopher Chief Executive Officer - RECURSION PHARMACEUTICALS, INC.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 974,229 | 977 | 975,206 |
| Value | $4,510,680.27 | $4,523.51 | $4,515,203.78 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 09/10/2025 | DDS | 100,000 | Direct | COM | $4.71 | $471,000.00 | 974,229 |
| 08/26/2025 | DDS | 100,000 | Direct | COM | $4.84 | $484,000.00 | 954,229 |
| 08/11/2025 | DDS | 100,000 | Indirect | COM | $5.28 | $528,000.00 | 0 |
| 08/11/2025 | DDS | 500,300 | Direct | COM | $5.28 | $2,641,584.00 | 1,004,619 |
| 08/11/2025 | DDS | 17,875 | Indirect | COM | $5.28 | $94,380.00 | 0 |
| 03/27/2025 | DDS | 138,574 | Direct | COM | $6.04 | $836,986.96 | 1,117,450 |
| 03/06/2025 | DDS | 20,000 | Direct | COM | $6.37 | $127,400.00 | 1,256,024 |
| 03/05/2025 | DDS | 20,000 | Direct | COM | $6.58 | $131,600.00 | 1,256,024 |
| 02/06/2025 | DDS | 20,000 | Direct | COM | $8.12 | $162,400.00 | 1,273,156 |
| 02/05/2025 | DDS | 20,000 | Direct | COM | $7.68 | $153,600.00 | 1,273,156 |
| 01/10/2025 | DDS | 20,000 | Direct | COM | $7.05 | $141,000.00 | 736,633 |
| 01/08/2025 | DDS | 20,000 | Direct | COM | $7.31 | $146,200.00 | 736,633 |
| 12/05/2024 | DDS | 20,000 | Direct | COM | $7.12 | $142,400.00 | 736,633 |
| 12/04/2024 | DDS | 20,000 | Direct | COM | $7.16 | $143,200.00 | 736,633 |
| 11/14/2024 | DDS | 20,000 | Direct | COM | $7.35 | $147,000.00 | 762,656 |
| 11/13/2024 | DDS | 20,000 | Direct | COM | $7.74 | $154,800.00 | 762,656 |
| 10/03/2024 | DDS | 20,000 | Direct | COM | $6.08 | $121,600.00 | 762,656 |
| 10/02/2024 | DDS | 20,000 | Direct | COM | $6.16 | $123,200.00 | 762,656 |
| 09/05/2024 | DDS | 20,000 | Direct | COM | $6.14 | $122,800.00 | 762,656 |
| 09/04/2024 | DDS | 20,000 | Direct | COM | $6.04 | $120,800.00 | 762,656 |
| 08/08/2024 | DDS | 20,000 | Direct | COM | $6.50 | $130,000.00 | 758,738 |
| 08/07/2024 | DDS | 30,000 | Direct | COM | $7.10 | $213,000.00 | 758,738 |
| 07/11/2024 | DDS | 50,000 | Direct | COM | $7.47 | $373,500.00 | 758,738 |
| 07/10/2024 | DDS | 50,000 | Direct | COM | $7.48 | $374,000.00 | 758,738 |
| 06/06/2024 | DDS | 50,000 | Direct | COM | $9.00 | $450,000.00 | 708,738 |
| 1 2 3 4 5 6 7 8 Next Last You are at page 1 of 8 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research